+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The Small Molecule Prefilled Syringes Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • PDF Icon

    Report

  • 161 Pages
  • November 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5509623
Prefilled syringes have several advantages over traditional vial packaging, including ease of use. Prefilled syringes obviate the need for the processes that are required before using a drug in a vial. It also helps to eliminate dosing errors because prefilled syringes contain the exact dose. Many pharmaceutical manufacturers overfill vials by up to 25% to ensure that the end user receives the correct dose. However, overfilling can result in errors that are virtually eliminated with prefilled syringes. With the introduction of more expensive biotech drugs, this is advantageous because it means less waste, particularly if some vaccines are in short supply or extremely expensive.



Market Dynamics


Market players are focused on product launches or approvals, which is expected to contribute to the growth of the global small molecule prefilled syringes market over the forecast period. For instance, in March 2018, Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) 0.3 mg prefilled syringe (PFS) as a new method of administering the medicine to treat all forms of diabetic retinopathy.

Market players are focused on launching manufacturing capabilities for prefilled syringes. This is expected to drive the market growth over the forecast period. For instance, in July 2019, Terumo Corporation, based in Japan, announced the construction of an additional production facility for pre-filled syringes at its subsidiary Terumo Yamaguchi D&D.

Market players focused on product launches is expected to propel the growth of the global small molecule prefilled syringes market. For instance, in March 2020, Dr. Reddy's Laboratories Ltd., a leading multinational pharmaceutical company, announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe, a therapeutic equivalent generic version of Narcan (naloxone hydrochloride) Injection USP in India.

Key features of the study:

  • This report provides an in-depth analysis of global small molecule prefilled syringes market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global small molecule prefilled syringes market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Sanofi, Viatris Inc. (Mylan N.V.), AstraZeneca Plc, F. Hoffmann-La Roche AG (Genentech, Inc.), Sun Pharmaceutical Industries Ltd., Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, and McKesson Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global small molecule prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global small molecule prefilled syringes market

Detailed Segmentation:


Global Small Molecule Prefilled Syringes Market, By Drug Class:

  • Cardiovascular Drugs
  • Neurology Drugs
  • Analgesics
  • Adjuvants
  • Others

Global Small Molecule Prefilled Syringes Market, By Material Type :

  • Glass
  • Plastic & Polymer

Cardiovascular Ultrasound Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Small Molecule Prefilled Syringes Market, By Region:

  • North America
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa

  • Company Profiles
  • Sanofi *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Viatris Inc. (Mylan N.V.)
  • AstraZeneca Plc
  • F. Hoffmann-La Roche AG (Genentech, Inc.)
  • Sun Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Fresenius Kabi AG
  • McKesson Corporation.
Frequently Asked Questions about the Small Molecule Prefilled Syringes Market

What is the estimated value of the Small Molecule Prefilled Syringes Market?

The Small Molecule Prefilled Syringes Market was estimated to be valued at US$17419.4 Million in 2021.

What is the growth rate of the Small Molecule Prefilled Syringes Market?

The growth rate of the Small Molecule Prefilled Syringes Market is 5.5%, with an estimated value of US$25411.8 Million by 2028.

What is the forecasted size of the Small Molecule Prefilled Syringes Market?

The Small Molecule Prefilled Syringes Market is estimated to be worth US$25411.8 Million by 2028.

Who are the key companies in the Small Molecule Prefilled Syringes Market?

Key companies in the Small Molecule Prefilled Syringes Market include Sanofi, Viatris Inc. (Mylan N.V.), AstraZeneca Plc, F. Hoffmann, La Roche AG (Genentech, Inc.), Sun Pharmaceutical Industries Ltd., Pfizer Inc., Dr. Reddy’s Laboratories Ltd. and Fresenius Kabi AG.

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Drug Class
  • Market Snippet, By Material Type
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Porter’s Analysis
  • Industry Trends
  • Key Highlights
  • Epidemiology
  • Reimbursement Scenario
  • Regulatory Scenario
  • Product Launch and Approvals
  • Acquisition and Collaboration Scenario

4. COVID – 19 Impact Analysis
  • COVID-19 Epidemiology
  • Impact of COVID-19 on Demand and Supply of Small molecule prefilled syringes
  • Impact of COVID-19 on the overall Healthcare Sector

5. Global Small Molecule Prefilled Syringes Market, By Drug Class, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Cardiovascular Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Neurology Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Analgesics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Adjuvants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Small Molecule Prefilled Syringes Market, By Material Type, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Glass
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Plastic & Polymer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Small Molecule Prefilled Syringes Market, By Distribution Channel, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017- 2028
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Small Molecule Prefilled Syringes Market, By Region, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, By Region, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • Regional Trends
  • North America
  • Market Size and Forecast, By Drug Class,2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Material Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Market Size and Forecast, By Drug Class,2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Material Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Market Size and Forecast, By Drug Class,2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Material Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Drug Class,2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Material Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Market Size and Forecast, By Drug Class,2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Material Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Drug Class,2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Material Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape
  • Company Profiles
  • Sanofi *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Viatris Inc. (Mylan N.V.)
  • AstraZeneca Plc
  • F. Hoffmann-La Roche AG (Genentech, Inc.)
  • Sun Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Fresenius Kabi AG
  • McKesson Corporation.

  • Analyst Views

10. Section
  • Research Methodology
  • About us
  • Contact

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Sanofi
  • Viatris Inc. (Mylan N.V.)
  • AstraZeneca Plc
  • F. Hoffmann-La Roche AG (Genentech, Inc.)
  • Sun Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Fresenius Kabi AG
  • McKesson Corporation.